Evidence map›Paper›PMID 19798426›Full record

ArticlePLoS pathogens2009

RNase L mediated protection from virus induced demyelination.

Derek D C Ireland, Stephen A Stohlman, David R Hinton, Parul Kapil, Robert H Silverman, Roscoe A Atkinson, Cornelia C Bergmann

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2021
    Pooled it
  2. tRNA modifications in viral replication.The Journal of biological chemistry · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Real-time 2-5A kinetics suggest that interferons β and λ evade global arrest of translation by RNase L.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Derek D C IrelandDepartment of Neuroscience, Lerner Research Institute, The Cleveland Clinic, Cleveland, Ohio, United States of America.
Stephen A Stohlman
David R Hinton
Parul Kapil
Robert H Silverman
Roscoe A Atkinson
Cornelia C Bergmann
Cleveland Clinic Lerner College of Medicine · USUniversity of Southern California · US

Funding

VIRUS ENTRY AS A DETERMINANT OF MOUSE HEPATITIS VIRUS NEUROTROPISMP01NS018146 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMANN, CORNELIA · 1985 to 2007
$10.4M
REGULATION OF 2-5A-DEPENDENT RNASE LEVELS OF INTERFERONR01CA044059 · NCI · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SILVERMAN, ROBERT H. · 1986 to 2015
$6.1M
Immune Regulation of CNS Viral RecrudescenceR01AI047249 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMANN, CORNELIA · 2001 to 2010
$3.1M
Immune Regulation of Viral RecrudescenceR56AI047249 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI BERGMANN, CORNELIA · 2012 to 2012
$393k
NCI NIH HHS CA044059NCI NIH HHS R01 CA044059NIAID NIH HHS AI47249NIAID NIH HHS R01 AI047249NIAID NIH HHS R56 AI047249NINDS NIH HHS NS18146NINDS NIH HHS P01 NS018146
6 · The paper itself

Abstract

IFN-alpha/beta plays a critical role in limiting viral spread, restricting viral tropism and protecting mice from neurotropic coronavirus infection. However, the IFN-alpha/beta dependent mechanisms underlying innate anti-viral functions within the CNS are poorly understood. The role of RNase L in viral encephalomyelitis was explored based on its functions in inhibiting translation, inducing apoptosis, and propagating the IFN-alpha/beta pathway through RNA degradation intermediates. Infection of RNase L deficient (RL(-/-)) mice with a sub-lethal, demyelinating mouse hepatitis virus variant revealed that the majority of mice succumbed to infection by day 12 p.i. However, RNase L deficiency did not affect overall control of infectious virus, or diminish IFN-alpha/beta expression in the CNS. Furthermore, increased morbidity and mortality could not be attributed to altered proinflammatory signals or composition of cells infiltrating the CNS. The unique phenotype of infected RL(-/-) mice was rather manifested in earlier onset and increased severity of demyelination and axonal damage in brain stem and spinal cord without evidence for enhanced neuronal infection. Increased tissue damage coincided with sustained brain stem infection, foci of microglia infection in grey matter, and increased apoptotic cells. These data demonstrate a novel protective role for RNase L in viral induced CNS encephalomyelitis, which is not reflected in overall viral control or propagation of IFN-alpha/beta mediated signals. Protective function is rather associated with cell type specific and regional restriction of viral replication in grey matter and ameliorated neurodegeneration and demyelination.

Indexed as

AnimalsApoptosisBrainCoronavirus InfectionsDemyelinating DiseasesEncephalitis, ViralEndoribonucleasesFlow CytometryFluorescent Antibody TechniqueInflammationInterferon-alphaInterferon-betaMiceMice, Inbred C57BLMice, Mutant StrainsMurine hepatitis virus2-5A-dependent ribonucleaseEndoribonucleasesInterferon-alphaInterferon-beta

Identifiers

PMID19798426
PMCPMC2745574
OpenAlexW2001951173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.